Top Markets
#1 Pleasing Gold Pleasing Gold +1,500.13%
#2 PulseChain PulseChain +58.12%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.60%
#4 BOOK OF MEME BOOK OF MEME +31.43%
#5 Ontology Gas Ontology Gas +30.17%
#6 ConstitutionDAO ConstitutionDAO +25.35%
#7 Neiro Neiro +25.24%
#8 Pump.fun Pump.fun +21.05%
#9 Unit Pump Unit Pump +21.05%
#10 Collect on Fanable Collect on Fanable +20.62%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
Rank in Stocks #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Share Price
$0.53499835
Market Cap
$40.24M
Change (1 day)
2.50%
Change (1 year)
-58.07%
Country
JP
Trade Chordia Therapeutics Inc. (190A)

Category

Healthcare
Stock price history for Chordia Therapeutics Inc. (190A)
Highest end of day price: $0.53 on 2026-08-01

Lowest end of day price: $1.06 on 2024-06-01
Stock price history of Chordia Therapeutics Inc. from 2024 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 10.93%
2025 -61.05%
2024 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.13 37.98%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.62%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 7.04%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $131.42 388.73%
US